Medifast Expands Meal Replacement Line with New Medifast to go!™ Products Medifast adds Cereal Crunches, Cheese Puffs, and a new Ready-to-Drink Shake to Medifast to go!™
OWINGS MILLS, Md., July 23, 2012 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven portion-controlled weight-loss products and programs, announced today the launch of five new Medifast Meal options, including Mixed Berry and Cinnamon & Brown Sugar Cereal Crunch, Parmesan and Chili Nacho Cheese Puffs, and a Mocha Ready-to-Drink Shake. New products are available for purchase at choosemedifast.com, through a free Take Shape For Life Health Coach, or at a Medifast Weight Control Center.
Medifast's Mixed Berry and Cinnamon & Brown Sugar Cereal Crunch complement the current breakfast options, which include eggs and pancakes. The Parmesan and Chili Nacho Cheese Puffs combine crunch and savory flavor, and the Medifast Mocha Ready-to-Drink Shake adds a caffeinated option to the current line of Ready-to-Drink Shakes. All five new Medifast Meals expand the Medifast to go!™ product line and are full of vitamins and minerals, fiber, and protein—and are only 90-110 calories.
"We understand that our clients lead busy lives, and, in listening to their needs, we saw that expanding our Medifast to go!™ product line is critical to their success," said Michael MacDonald, Chairman and Chief Executive Officer, Medifast, Inc. "Options like the Mixed Berry and Cinnamon & Brown Sugar Cereal Crunch, the Parmesan and Chili Nacho Cheese Puffs, and the Mocha Ready-to-Drink Shake help support our clients' weight-loss and health goals."
The new Medifast Meals are completely interchangeable with other Medifast Meals on the Medifast 5 & 1 Plan®. Medifast products and programs have been recommended by over 20,000 doctors since 1980. Clients can expect to lose up to two to five pounds per week and up to 20 pounds their first month on the Medifast 5 & 1 Plan®, in which clients eat five Medifast Meals and one Lean & Green Meal™—consisting of lean protein and non-starchy vegetables—each day.
Medifast (NYSE: MED) is the leading easy-to-use, clinically proven, portion-controlled weight-loss program. Medifast has been recommended by over 20,000 doctors and used by over one million customers since 1980. It is committed to enriching lives by providing innovative choices for lasting health. Medifast programs have been proven effective through studies by major university teaching hospitals. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) the Take Shape For Life personal coaching division, 3) Medifast Weight Control Centers, and 4) a national network of physicians. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, log onto http://www.choosemedifast.com.
Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's objectives, strategies, plans, goals, or targets contained herein are also considered forward-looking statements. Medifast believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Medifast's inability to attract and retain independent Associates and Members, stability in the pricing of print, TV, and Direct Mail marketing initiatives affecting the cost to acquire customers, increases in competition, litigation, regulatory changes, and its planned growth into new domestic and international markets and new channels of distribution. Although Medifast's believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
SOURCE Medifast, Inc.